metricas
covid
Buscar en
Clínica e Investigación en Ginecología y Obstetricia
Toda la web
Inicio Clínica e Investigación en Ginecología y Obstetricia Síndrome de Sjögren y gestación. A propósito de un caso
Journal Information
Vol. 30. Issue 5.
Pages 163-166 (January 2003)
Share
Share
Download PDF
More article options
Vol. 30. Issue 5.
Pages 163-166 (January 2003)
Full text access
Síndrome de Sjögren y gestación. A propósito de un caso
Visits
5896
P.A. Doblas, I. Eguiluz, M.A. Barber, J.V. Hijano, G.M. Franco, C. Baena, T. Pérez-Reyes, E. López-Torres, E. Pérez de la Blanca, M. Abehsera
Departamento de Ginecología y Obstetricia. Hospital Materno-Infantil Hospital Regional Carlos Haya Málaga España
This item has received
Article information
Summary

In this article we talk about Sjögren syndrome, an autoimmune disease of unknown aetiology, which has a diverse clinical presentation with no specific treatment, only symptomatic. We present the case of a pregnant woman with this disease diagnosed in childhood. She had a pregnancy that progressed without important complications, and the pre-existing clinical state was not exacerbated by pregnancy. The disease did not influence the development of the pregnancy.

Resumen

En este artículo hablamos del síndrome de Sjögren,enfermedad autoinmune de etiología desconocida quecursa con una clínica muy diversa y que no tiene tratamiento específico, sólo sintomático. Presentamos elcaso de una paciente gestante con esta enfermedadque le fue diagnosticada en la infancia y que tuvo unembarazo que cursó sin mayores complicaciones. Laclínica preexistente no se exacerbó en el curso delembarazo y la enfermedad no influyó en el desarrollode la gestación.

Full text is only aviable in PDF
Bibliografía
[1.]
RI Fox, G Pearson, JH. Vaughman.
Detection of Epstein- Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjögren’s syndrome.
J Immunol, 137 (1989), pp. 3162-3168
[2.]
F Homo-Delarche, F Fitzpatrick, N Christeff, EA Nunez, JF Bach, M. Dardenne.
Sex steroids, glucocorticoids, stress and autoimmunity.
J Steroid Biochem Mol Biol, 40 (1991), pp. 619-637
[3.]
R Fox, I. Saito.
Sjögren’s syndrome: immunologic and neuroendocrine mechanisms.
Adv Exp Med Biol, 350 (1994), pp. 609-621
[4.]
D. Sullivan.
Possible mechanisms involved in reduced tear secretion in Sjögren’s syndrome.
pp. 13-19
[5.]
Ikuko MD. Toda.
Autoantigens and Sjogren syndrome. Cornea 2002;2(Suppl 1):S13-S6. 6. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjogren’s syndrome.
J Clin Pathol, 21 (1968), pp. 656
[6.]
JS Greenspan, TE Daniels, N Talal, RA. Sylvester.
The histopathology of Sjogren’s syndrome in labial salivary gland biopsies.
Oral Surg, 37 (1974), pp. 217
[7.]
C Vitali, HM Moutsopoulos, S. Bombardieri.
The European Community Study Group on diagnostic criteria for Sjogren’s syndrome: sensitivity and specificity of tests for ocular and oral involvement in Sjogren’s syndrome.
Ann Rheum Dis, 53 (1994), pp. 637
[8.]
H Tonami, K Higashi, M Matoba, H Yokota, I Yamamoto, S. Sugai.
A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjogren syndrome.
Journal of Computer Assisted Tomography, 25 (2001), pp. 262-268
[9.]
MH. Friedlaender.
Ocular manifestations of Sjogren’s syndrome: keratoconjunctivitis sicca.
Rheum Dis Clin North Am, 18 (1992), pp. 591-608
[10.]
A Goules, S Masouridi, AGI Tzioufas, P John, A Skopouli, N Fotini, et al.
Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome.
Medicine, 79 (2000), pp. 241-249
[11.]
HM. Moutsopoulos.
Sjogren’s syndrome.
10, pp. 131-135
[12.]
C. Lafitte.
Neurological manifestations in Sjogren syndrome.
Archives of Neurology, 57 (2000), pp. 1657-1658
[13.]
SI Taura, Y Murat, W Aung, R Ishida, L Zhang, M Hossain, et al.
Decreased thyroid uptake of Tc-99m pertechnetate in patients with advanced-stage Sjogren syndrome: evaluation using salivary gland scintigraphy.
Clinical Nuclear Medicine, 27 (2002), pp. 265-269
[14.]
A Vitali, S Bombardieri, HM Moutopoulos, et al.
Preliminary criteria for the classification of Sjogren’s syndrome.
Arthritis Rheum, 36 (1993), pp. 341-347
[15.]
CS Williams, E Butler, G. Roman.
Treatment of myelopathy in Sjogren syndrome with a combination of prednisone and cyclophosphamide.
Archives of Neurology, 58 (2001), pp. 815-819
[16.]
H Yamada, EH Kato, Y Ebina, M Moriwaki, R Yamamoto, I Furuta, et al.
Fetal treatment of congenital heart block ascribed to anti-SSA antibody: case reports with observation of cardiohemodynamics and review of the literature.
Am J Reprod Immunol, 42 (1999), pp. 226-232
[17.]
E Feist, T Dorner, A Wagenmann, R Chaoui, W Rohde, GR Burmester, et al.
Successful therapeutic management of risk pregnancy in primary Sjogren syndrome with plasmapheresis and dexamethasone.
Z Rheumatol, 55 (1996), pp. 127-132
[18.]
A Kikuchi, T Okai, Y. Taketani.
Pulmonary embolism associated with Sjogren’s syndrome in pregnancy.
J Obstet Gynaecol Res, 22 (1996), pp. 421-423
[19.]
CM Arroyave, Ledezma F Puente, Amoroso G Montiel, Garcia AC. Martinez.
Myocardiopathy diagnosed in utero in a mother with SS-A antibodies treated with plasmapheresis.
Ginecol Obstet Mex, 63 (1995), pp. 134-137
[20.]
H Julkunen, R Kaaja, P Kurki, T Palosuo, C. Friman.
Fetal outcome in women with primary Sjogren’s syndrome. A retrospective case-control study.
Clin Exp Rheumatol, 13 (1995), pp. 65-71
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos